Ad
related to: covid-19 update today worldwide
Search results
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
CBS 47 Fresno· 4 days agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19
AstraZeneca withdraws Covid-19 vaccine, citing low demand | CNN Business
CNN.com· 6 days agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...
Fed Rate Cuts Remain Elusive. Why Markets Can’t Count on Inflation Data for Insight and 5 Other...
Barrons.com· 14 hours agoFed officials are also struggling to get a clear idea of what’s happening. There will be plenty of ...
Stock market today: Wall Street coasts toward the close of another winning week
Houston Chronicle· 3 days agoU.S. stocks are coasting toward the close of another winning week on Friday. The S&P 500 was 0.1%...
Dogness Announces Entry into US$5.0 Million Private Placement
KTBS Shreveport· 4 days agoDogness (International) Corporation ("Dogness" or the "Company") (NASDAQ: DOGZ), a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, ...
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 11 hours agoNovavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript May 12, 2024 Novavax, Inc. isn’t one of...
Earnings call: Radiant Logistics posts loss amid challenging market
Investing.com· 2 days agoRadiant Logistics, Inc. (NYSE: RLGT ) reported a net loss of $703,000 for the quarter ended March...
MPR News Podcasts
MPR News· 3 days agoCheck out MPR News podcasts, the latest from Minnesota Today to in-depth conversations on news and culture with Angela Davis and stories from around Minnesota with Cathy Wurzer.
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 4 days agoTransat A.T. Inc. ("Transat" or the "Corporation") announced today that it will likely not achieve its adjusted EBITDA margin1 forecast for fiscal 2024. Persistent operational ...
Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home...
Digital Journal· 5 days ago...available market for the company's products will not be as large as expected, the company's products will not be able to penetrate one or more targeted markets, revenues will not be sufficient to meet the company's cash needs, fund further development, as well as uncertainties relative to the ...